GRID2 Antikörper (C-Term)
Kurzübersicht für GRID2 Antikörper (C-Term) (ABIN603251)
Target
Alle GRID2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Recognizes the C-Terminus of Glutamate receptor delta 1 and delta 2. Species cross-reactivity: rat and human. Reacts weakly with mouse. Species sequence homology: primates.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic linear peptide to the C-Terminus, conjugated to BSA.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (1:5000)
Usage: Suitable for use in Western blot: 1:5000. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.4, 150 mM sodium chloride, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. For long-term storage and to avoid freeze-thaw cycles, aliquot and store at -20°C. Aliquots are stable for at least 1 year at -20°C.
-
-
- GRID2 (Glutamate Receptor, Ionotropic, delta 2 (GRID2))
-
Pathways
- Synaptic Membrane
Target
-